|
DYRK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.11859998830744E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.93529999592946E-08 |
| Normal-vs-Stage2 |
1.941820E-03 |
| Normal-vs-Stage3 |
4.230600E-04 |
| Normal-vs-Stage4 |
1.001760E-01 |
| Stage1-vs-Stage2 |
9.775800E-01 |
| Stage1-vs-Stage3 |
6.750400E-01 |
| Stage1-vs-Stage4 |
9.525400E-01 |
| Stage2-vs-Stage3 |
7.308400E-01 |
| Stage2-vs-Stage4 |
9.728400E-01 |
| Stage3-vs-Stage4 |
7.807800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.08520003883461E-09 |
| Normal-vs-AfricanAmerican |
7.81929999971176E-07 |
| Normal-vs-Asian |
1.224420E-01 |
| Caucasian-vs-AfricanAmerican |
6.922800E-01 |
| Caucasian-vs-Asian |
4.189400E-01 |
| AfricanAmerican-vs-Asian |
3.206200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44119996334535E-09 |
| Normal-vs-Female |
2.31929999650049E-08 |
| Male-vs-Female |
3.468000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.010100E-04 |
| Normal-vs-Extreme_Weight |
2.43559999999476E-05 |
| Normal-vs-Obese |
4.41430000330811E-08 |
| Normal-vs-Extreme_Obese |
8.132400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.922200E-01 |
| Normal_Weight-vs-Obese |
8.242100E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.641200E-01 |
| Extreme_Weight-vs-Obese |
9.898400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.194400E-01 |
| Obese-vs-Extreme_Obese |
1.000240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.379200E-04 |
| Normal-vs-Age(41-60Yrs) |
3.20869997239015E-11 |
| Normal-vs-Age(61-80Yrs) |
3.34739999996447E-06 |
| Normal-vs-Age(81-100Yrs) |
2.155000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.094600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.958300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.172000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.221200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.480200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.289600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.52899914951377E-11 |
| Normal-VS-Type2 PRCC |
4.776400E-03 |
| Normal-VS-KIRP CIMP |
1.998410E-02 |
| Normal-VS-Unclassified PRCC |
3.027900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.03550000000119E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.558400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.046800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.383600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.362100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.260600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.717420E-03 |
| Normal-vs-N1 |
7.644800E-04 |
| Normal-vs-N2 |
2.118200E-03 |
| N0-vs-N1 |
2.396400E-02 |
| N0-vs-N2 |
2.137800E-01 |
| N1-vs-N2 |
7.124400E-01 |
|
|
